FDA finalizes rule allowing mail-order abortion pills

France Nouvelles Nouvelles

FDA finalizes rule allowing mail-order abortion pills
France Dernières Nouvelles,France Actualités
  • 📰 latimes
  • ⏱ Reading Time:
  • 20 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 82%

The Food and Drug Administration on Tuesday finalized a rule change that allows women seeking abortion pills to get them through the mail, replacing a long-standing requirement that they pick up the medicine in person

pills to get them through the mail, replacing a long-standing requirement that they pick up the medicine in person.

Two drugmakers that make brand-name and generic versions of abortion pills requested the latest FDA label update. Agency rules require a company to file an application before modifying dispensing restrictions on drugs. More than half of U.S. abortions are now done with pills rather than surgery, according to the Guttmacher Institute, a research group that supports abortion rights.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

latimes /  🏆 11. in US

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

House investigation finds FDA, drug firm Biogen ignored internal concerns for Alzheimer's drugHouse investigation finds FDA, drug firm Biogen ignored internal concerns for Alzheimer's drugA congressional investigation into the FDA's review process for an Alzheimer's treatment found that the agency 'deviated' from its standard procedures to approve the Aduhelm drug with inconsistent data.
Lire la suite »

FDA decision on experimental Alzheimer's drug expected this week | CNNFDA decision on experimental Alzheimer's drug expected this week | CNNThe US Food and Drug Administration could decide this week whether to grant accelerated approval to the experimental Alzheimer's drug lecanemab, according to Eisai and Biogen, the companies that make the drug.
Lire la suite »

Controversial Alzheimer's drug, explained: What to know about Aduhelm, FDA and scathing reportControversial Alzheimer's drug, explained: What to know about Aduhelm, FDA and scathing reportThe FDA's approval process of Alzheimer’s drug Aduhelm has been deemed “rife with irregularities,” according to a congressional investigation. Here are takeaways from the report.
Lire la suite »

FDA set to make decision on experimental Alzheimer's drug this weekFDA set to make decision on experimental Alzheimer's drug this weekThe Food and Drug Administration is expected to decide by Friday whether to grant accelerated approval for Eisai and Biogen's experimental Alzheimer's drug, lecanemab.
Lire la suite »

Sesame joins the major food allergens list, FDA saysSesame joins the major food allergens list, FDA saysSesame has joined the list of major food allergens defined by law, according to the U.S. Food and Drug Administration.
Lire la suite »

Sesame added to major food allergens list by FDASesame added to major food allergens list by FDAAs of Jan. 1, sesame has officially joined the list of major food allergens, the U.S. Food and Drug Administration said.
Lire la suite »



Render Time: 2025-03-06 21:35:15